Daytime Severe Cold And Flu Tablet, Coated
NDC Package 37808-178-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Daytime Severe Cold And Flu (acetaminophen, dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride) tablets is take only as directed (see overdose warning) do not exceed 4 doses per 24 hoursadults and children 12 years and overtake 2 caplets every 4 hourschildren 4 to under 12 yearsask a doctorchildren under 4 yearsdo not use. This formulation utilizes a tablet, coated delivery system. Marketed by Heb, this product is identified by NDC 37808-178 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
37808-178-03
Package Description
2 BLISTER PACK in 1 CARTON / 12 TABLET, COATED in 1 BLISTER PACK
Product Code
11-Digit Billing Format
37808017803
RxNorm Crosswalk
  • RxCUI: 1110988 - acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet
  • RxCUI: 1110988 - acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet
  • RxCUI: 1110988 - APAP 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet

Clinical Specifications

Proprietary Name
Daytime Severe Cold And Flu Maximum Strength
Non-Proprietary Name
Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, And Phenylephrine Hydrochloride
Substance Name
Acetaminophen; Dextromethorphan Hydrobromide; Guaifenesin; Phenylephrine Hydrochloride
Dosage Form
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
Take only as directed (see overdose warning) do not exceed 4 doses per 24 hoursadults and children 12 years and overtake 2 caplets every 4 hourschildren 4 to under 12 yearsask a doctorchildren under 4 yearsdo not use

Regulatory & Marketing

Labeler Name
Heb
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-01-2016
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 37808-178-03 identifies a specific commercial package of 2 blister pack in 1 carton / 12 tablet, coated in 1 blister pack of Daytime Severe Cold And Flu Maximum Strength, a human over the counter drug labeled by Heb. This tablet, coated is formulated for oral use and contains acetaminophen; dextromethorphan hydrobromide; guaifenesin; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Heb on May 01, 2016. The current certification is valid through December 31, 2026.

How is this Heb product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 37808017803. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
37808-178-03
11-Digit CMS (5-4-2)
37808-0178-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.